Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko DeWire

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Tennessee Medicine : Journal of the Tennessee Medical Association|February 9, 2005
The "black box" controversyJudy Regan, Mariko DeWire, Brian Whitby, et al.
Practical Radiation Oncology|March 10, 2017
Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literatureChristopher Freese, Vinita Takiar, Maryam Fouladi, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experienceMark Van Poppel, Paul Klimo, Mariko Dewire, et al.
Oncotarget|October 4, 2017
BMI-1 is a potential therapeutic target in diffuse intrinsic pontine gliomaShiva Senthil Kumar, Satarupa Sengupta, Kyungwoo Lee, et al.
Journal of Neuro-Oncology|December 1, 2014
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosisRalph Salloum, Mariko DeWire, Adam Lane, et al.
Molecular Cancer Research : MCR|August 18, 2020
Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 ModulationShiva Senthil Kumar, Satarupa Sengupta, Xiaoting Zhu, et al.
Acta Neuropathologica Communications|January 12, 2021
A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targetsXiaoting Zhu, Margot A Lazow, Austin Schafer, et al.
Journal of Neuro-Oncology|January 14, 2015
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelaeDavid Gass, Mariko Dewire, Lionel Chow, et al.
Neuro-Oncology|February 4, 2021
OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypesYunfei Liao, Zaili Luo, Yaqi Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytomaHemant K Bid, Aaron Kibler, Doris A Phelps, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Tennessee Medicine : Journal of the Tennessee Medical Association|February 9, 2005
The "black box" controversyJudy Regan, Mariko DeWire, Brian Whitby, et al.
Practical Radiation Oncology|March 10, 2017
Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literatureChristopher Freese, Vinita Takiar, Maryam Fouladi, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experienceMark Van Poppel, Paul Klimo, Mariko Dewire, et al.
Oncotarget|October 4, 2017
BMI-1 is a potential therapeutic target in diffuse intrinsic pontine gliomaShiva Senthil Kumar, Satarupa Sengupta, Kyungwoo Lee, et al.
Journal of Neuro-Oncology|December 1, 2014
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosisRalph Salloum, Mariko DeWire, Adam Lane, et al.
Molecular Cancer Research : MCR|August 18, 2020
Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 ModulationShiva Senthil Kumar, Satarupa Sengupta, Xiaoting Zhu, et al.
Acta Neuropathologica Communications|January 12, 2021
A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targetsXiaoting Zhu, Margot A Lazow, Austin Schafer, et al.
Journal of Neuro-Oncology|January 14, 2015
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelaeDavid Gass, Mariko Dewire, Lionel Chow, et al.
Neuro-Oncology|February 4, 2021
OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypesYunfei Liao, Zaili Luo, Yaqi Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytomaHemant K Bid, Aaron Kibler, Doris A Phelps, et al.
Pageof 3